Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2300 of 3284 entries
View as:

PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction

Phase: N/A Priority: Normal
NCT ID: NCT05555290 Org: User:
Start: 09/28/22 End: 11/18/24 Due: 11/18/25

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men

Phase: N/A Priority: Normal
NCT ID: NCT03400488 Org: User:
Start: 01/16/18 End: 06/12/18 Due: 06/12/19

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

Phase: N/A Priority: Normal
NCT ID: NCT00261352 Org: User:
Start: 03/31/05 End: 12/31/06 Due: 12/31/07

Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00494234 Org: User:
Start: 06/15/07 End: 12/21/22 Due: 12/21/23

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01713075 Org: User:
Start: 11/30/12 End: 12/31/15 Due: 12/31/16

A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693

Phase: N/A Priority: Normal
NCT ID: NCT05919069 Org: User:
Start: 06/16/23 End: 09/16/24 Due: 09/16/25

A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03258515 Org: User:
Start: 09/06/17 End: 03/24/18 Due: 03/24/19

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Phase: N/A Priority: Normal
NCT ID: NCT00391846 Org: User:
Start: 10/31/06 End: 01/31/09 Due: 01/31/10

The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China

Phase: N/A Priority: Normal
NCT ID: NCT02143739 Org: User:
Start: 06/07/14 End: 09/15/16 Due: 09/15/17

Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02268214 Org: User:
Start: 11/11/14 End: 08/25/17 Due: 08/25/18

An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD.

Phase: N/A Priority: Normal
NCT ID: NCT05492877 Org: User:
Start: 11/14/22 End: 08/12/24 Due: 08/12/25

GALLANT 22 Tesaglitazar vs. Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00252837 Org: User:
Start: 04/30/05 End: 12/31/06 Due: 12/31/07

Risk of Acute Kidney Injury Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments

Phase: N/A Priority: Normal
NCT ID: NCT01377935 Org: User:
Start: 08/31/09 End: 12/31/15 Due: 12/31/16

Symbicort in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00611520 Org: User:
Start: 09/30/05 End: - Due: -

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02632526 Org: User:
Start: 02/10/16 End: 08/26/16 Due: 08/26/17

Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00979134 Org: User:
Start: 10/21/09 End: 03/05/15 Due: 03/05/16

Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02814643 Org: User:
Start: 07/01/16 End: 01/24/17 Due: 01/24/18

Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China

Phase: N/A Priority: Normal
NCT ID: NCT03156985 Org: User:
Start: 08/16/17 End: 01/27/21 Due: 01/27/22

To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.

Phase: N/A Priority: Normal
NCT ID: NCT01951599 Org: User:
Start: 10/09/13 End: 06/04/14 Due: 06/04/15

Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00389064 Org: User:
Start: 09/30/06 End: 04/30/08 Due: 04/30/09

Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01768403 Org: User:
Start: 09/30/10 End: 03/31/11 Due: 03/31/12

Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM

Phase: N/A Priority: Normal
NCT ID: NCT01525225 Org: User:
Start: 09/30/12 End: 06/30/13 Due: 06/30/14

A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.

Phase: N/A Priority: Normal
NCT ID: NCT03645434 Org: User:
Start: 10/10/18 End: 08/07/19 Due: 08/07/20

Ph II Early BC Pre-Surgical Biologic Study

Phase: N/A Priority: Normal
NCT ID: NCT00637026 Org: User:
Start: 07/31/03 End: 02/28/05 Due: 02/28/06

Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.

Phase: N/A Priority: Normal
NCT ID: NCT03219970 Org: User:
Start: 09/05/17 End: 10/28/20 Due: 10/28/21